CN Patent

CN101885722B — 杂环炔苯类化合物及其药用组合物和应用

Assigned to Healthquest Pharma Inc · Expires 2013-07-24 · 13y expired

What this patent protects

本发明公开了一种具有通式Ⅰ的化合物及其药学上可接受的酸或碱盐或立体异构体，该化合物及其药学上可接受的盐或立体异构体在制备治疗或预防肿瘤的药物中的应用。该类化合物并可以有效克服Gleevec诱发的耐药。式中各基团定义详见说明书。

USPTO Abstract

本发明公开了一种具有通式Ⅰ的化合物及其药学上可接受的酸或碱盐或立体异构体，该化合物及其药学上可接受的盐或立体异构体在制备治疗或预防肿瘤的药物中的应用。该类化合物并可以有效克服Gleevec诱发的耐药。式中各基团定义详见说明书。

Drugs covered by this patent

Patent Metadata

Patent number
CN101885722B
Jurisdiction
CN
Classification
—
Expires
2013-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Healthquest Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.